#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	18424	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2492	907.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1621	1621	C	1161	C,G	1160,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31266	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4172	933.8	0	.	n	.	0	T695C	SNP	695	695	T	1300	1300	C	1165	C,T,G,A	1158,5,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31266	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4172	933.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1942	1942	A	1332	A,C	1330,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31266	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4172	933.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2576	2576	C	1138	C,T	1137,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31266	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4172	933.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2650	2650	A	1135	A	1135	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31266	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4172	933.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3202	3202	C	1122	C,T	1120,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2610	folP	855	855	99.88	folP.l15.c4.ctg.1	1997	162.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1293	1295	AGC	244;247;246	A;G;C,G	244;247;245,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6792	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4083	207.4	1	SNP	p	S91F	1	.	.	271	273	TTC	916	918	TTC	244;246;250	T,G;T;C,A	243,1;246;248,2	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6792	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4083	207.4	1	SNP	p	D95G	1	.	.	283	285	GGC	928	930	GGC	256;254;260	G,C;G;C,T	255,1;254;259,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6792	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4083	207.4	1	SNP	p	G95N	0	.	.	283	285	GGC	928	930	GGC	256;254;260	G,C;G;C,T	255,1;254;259,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	2484	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1840	168.1	1	SNP	p	G45D	0	.	.	133	135	GGC	725	727	GGC	278;281;281	G,C;G;C	276,2;281;280	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1354	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1467	114.8	0	.	n	.	0	A197.	DEL	197	197	A	831	831	A	264	A,C	263,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6364	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3406	232.7	1	SNP	p	D86N	0	.	.	256	258	GAC	813	815	GAC	282;281;281	G;A,C;C	282;280,1;281	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6364	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3406	232.7	1	SNP	p	S87R	1	.	.	259	261	CGT	816	818	CGT	279;278;278	C,T,G;G,T;T,C	276,1,1;277,1;277,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6364	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3406	232.7	1	SNP	p	R87W	0	.	.	259	261	CGT	816	818	CGT	279;278;278	C,T,G;G,T;T,C	276,1,1;277,1;277,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6364	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3406	232.7	1	SNP	p	R87I	0	.	.	259	261	CGT	816	818	CGT	279;278;278	C,T,G;G,T;T,C	276,1,1;277,1;277,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6364	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3406	232.7	1	SNP	p	S88P	0	.	.	262	264	TCC	819	821	TCC	280;281;280	T;C;C	280;281;280	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5278	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3167	207.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1825	1827	GGC	257;253;253	G;G,T;C,A	257;252,1;252,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3057	201.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1555	1557	GCA	294;291;289	G,A,C;C;A	291,2,1;291;289	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3057	201.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1558	1560	ATC	288;288;289	A,T;T,G;C,G,A	287,1;287,1;287,1,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3057	201.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1570	1572	GTG	284;287;289	G;T;G	284;287;289	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3057	201.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1570	1572	GTG	284;287;289	G;T;G	284;287;289	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3057	201.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2074	2076	ACC	262;265;266	A;C;C,A	262;265;265,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3057	201.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2128	2130	GCG	264;263;262	G,C;C;G	263,1;263;262	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3057	201.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2128	2130	GCG	264;263;262	G,C;C;G	263,1;263;262	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3057	201.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2251	2253	AGC	252;251;254	A;G,T;C	252;250,1;254	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3057	201.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2260	2262	GGC	254;253;253	G;G;C,A	254;253;252,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3057	201.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2278	2280	CCG	258;259;261	C,G;C,A;G	256,2;258,1;261	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6848	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3708	230.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1969	1971	CCG	274;275;274	C;C;G	274;275;273	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3104	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2198	175.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	797	797	C	241	C	241	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	357	41.6	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	32;34;36	T;T;A	32;34;36	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	357	41.6	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	81;81;81	C;A;T	81;81;81	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	357	41.6	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	81;81;81	A;G;T	81;81;81	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	357	41.6	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	81;81;81	T;A;C,T	81;81;80,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	357	41.6	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	4;4;4	G;A;A	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	357	41.6	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	357	41.6	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	4;4;4	A;T;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	357	41.6	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	4;4;4	T;C;G	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	357	41.6	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	357	41.6	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	4;4;4	A;G;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	357	41.6	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	357	41.6	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	4;4;4	G;T;T	4;4;4	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3644	porB1b	1035	1035	98.76	porB1b.l15.c17.ctg.1	1934	234.0	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1176	1176	T	315	T,G	314,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3644	porB1b	1035	1035	98.76	porB1b.l15.c17.ctg.1	1934	234.0	1	SNP	p	G120K	0	.	.	358	360	GGT	903	905	GGT	291;290;291	G,T;G,C;T,C,G	290,1;289,1;288,2,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3644	porB1b	1035	1035	98.76	porB1b.l15.c17.ctg.1	1934	234.0	1	SNP	p	A121N	0	.	.	361	363	GCC	906	908	GCC	288;289;285	G;C,T,A;C,T,A	288;287,1,1;283,1,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3644	porB1b	1035	1035	98.76	porB1b.l15.c17.ctg.1	1934	234.0	1	SNP	p	A121D	0	.	.	361	363	GCC	906	908	GCC	288;289;285	G;C,T,A;C,T,A	288;287,1,1;283,1,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11586	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5294	272.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1826	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1471	154.6	1	SNP	p	V57M	1	.	.	169	171	ATG	702	704	ATG	303;305;306	A;T;G	302;304;306	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
